Altrova Health Inc. ROVA
CNSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.14% | 140.68% | |||
| Depreciation & Amortization | -62.86% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.45% | 164.84% | |||
| Operating Income | 0.42% | -130.19% | |||
| Income Before Tax | -39.85% | -129.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -39.85% | -129.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -39.85% | -129.79% | |||
| EBIT | 0.42% | -130.19% | |||
| EBITDA | -0.32% | -134.85% | |||
| EPS Basic | -42.86% | -115.38% | |||
| Normalized Basic EPS | 5.56% | -125.00% | |||
| EPS Diluted | -42.86% | -115.38% | |||
| Normalized Diluted EPS | 5.56% | -125.00% | |||
| Average Basic Shares Outstanding | 0.12% | 7.61% | |||
| Average Diluted Shares Outstanding | 0.12% | 7.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||